Giuseppe Giaccone – författare
Visar alla böcker från författaren Giuseppe Giaccone. Handla med fri frakt och snabb leverans.
10 produkter
Systemic Treatment of Non-Small Cell Lung Cancer
E-bok, 2012
353 kr
Lägg i varukorg
Lung cancer is the leading cause of cancer mortality worldwide, and non-small cell lung cancer (NSCLC) accounts for about 85% of all cases of lung cancer. Most patients present with advanced disease and five-year survival is low at about 15%. Surgery is the main treatment for early stage disease. …
Systemic Treatment of Non-Small Cell Lung Cancer
Häftad, 2012
559 kr
Lägg i varukorg
Lung cancer is the leading cause of cancer mortality worldwide, and non-small cell lung cancer (NSCLC) accounts for about 85% of all cases of lung cancer. Most patients present with advanced disease and five-year survival is low at about 15%. Surgery is the main treatment for early stage disease. …
Targeted Therapies in Oncology
Av Giuseppe Giaccone, Jean-Charles Soria
Häftad, 2019
1039 kr
Lägg i varukorg
Since the last edition of this book, major advances have been made in our understanding of key pathways that control tumor progression. This has led to the development of new anticancer agents that have the ability to block the activity of proteins involved in neoplastic cell development and …
Drug Resistance in the Treatment of Cancer
Av Herbert M. Pinedo, Giuseppe Giaccone
Häftad, 2007
1093 kr
Lägg i varukorg
The development of drug-resistant cancers is considered to be the most significant obstacle to the cure of cancer today. Nearly half of all patients with cancer suffer from tumours that are intrinsically resistant to chemotherapy, and most of the remaining half develop drug resistance during the …
Drug Resistance in the Treatment of Cancer
Av Herbert M. Pinedo, Giuseppe Giaccone
Inbunden, 1998
2918 kr
Lägg i varukorg
The development of drug-resistant cancers is considered to be the most significant obstacle to the cure of cancer today. Nearly half of all patients with cancer suffer from tumours that are intrinsically resistant to chemotherapy, and most of the remaining half develop drug resistance during the …
Targeted Therapies in Oncology
Av Giuseppe Giaccone, Jean-Charles Soria
E-bok, 2013
1231 kr
Lägg i varukorg
Since the last edition of this book, major advances have been made in our understanding of key pathways that control tumor progression. This has led to the development of new anticancer agents that have the ability to block the activity of proteins involved in neoplastic cell development and …
Principles of Molecular Oncology
Av Paul Workman, Olufunmilayo I. Olopade m. fl.
E-bok, 2008
2948 kr
Lägg i varukorg
Drawing on years of significant scientific advances and clinical developments, the editors of POMO III have thoroughly updated the highly praised first and second editions and added new chapters to reflect the knowledge emerging from research on genomics, proteomics, chemoprevention strategies, new …
Targeted Therapies in Oncology
Av Giuseppe Giaccone, Jean-Charles Soria
Inbunden, 2013
3147 kr
Lägg i varukorg
Since the last edition of this book, major advances have been made in our understanding of key pathways that control tumor progression. This has led to the development of new anticancer agents that have the ability to block the activity of proteins involved in neoplastic cell development and …
Targeted Therapies in Oncology
Av Giuseppe Giaccone, Jean-Charles Soria
E-bok, 2013
1231 kr
Lägg i varukorg
Since the last edition of this book, major advances have been made in our understanding of key pathways that control tumor progression. This has led to the development of new anticancer agents that have the ability to block the activity of proteins involved in neoplastic cell development and …
Principles of Molecular Oncology
Av Miguel H. Bronchud, MaryAnn Foote m. fl.
Inbunden, 2007
2249 kr
Lägg i varukorg
Drawing on years of significant scientific advances and clinical developments, the editors of POMO III have thoroughly updated the highly praised first and second editions and added new chapters to reflect the knowledge emerging from research on genomics, proteomics, chemoprevention strategies, new …
